Effect of aminoguanidine and cyclosporine on lung allograft rejection
- 1 July 1996
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 62 (1) , 207-212
- https://doi.org/10.1016/0003-4975(96)00296-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical trial of tacrolimus versus cyclosporine in lung transplantationThe Annals of Thoracic Surgery, 1995
- SELECTIVE INHIBITION OF NITRIC OXIDE PRODUCTION DURING CARDIAC ALLOGRAFT REJECTION CAUSES A SMALL INCREASE IN GRAFT SURVIVALTransplantation, 1995
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Nitric Oxide Novel Biology with Clinical RelevanceAnnals of Surgery, 1995
- Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase.The Journal of Experimental Medicine, 1995
- Induction of myocardial nitric oxide synthase by cardiac allograft rejection.Journal of Clinical Investigation, 1994
- The L-Arginine-Nitric Oxide PathwayNew England Journal of Medicine, 1993
- Cyclosporin A protects pancreatic islet cells from nitric oxide-dependent macrophage cytotoxicityFEBS Letters, 1992
- IMPROVED IMMUNOSUPPRESSION WITH AEROSOLIZED CYCLOSPORINE IN EXPERIMENTAL PULMONARY TRANSPLANTATION1Transplantation, 1992
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979